Report from the field: The diabetes prevention program: How the participants did it

Health Affairs

Volumn 28, Issue 1, 2009, Pages 57-62

  Brink, Susan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO; TROGLITAZONE;

ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; EXERCISE; GLUCOSE TOLERANCE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; LIVER INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PHYSICAL ACTIVITY; PROPHYLAXIS; PUBLIC HEALTH; TREATMENT OUTCOME; ECONOMICS; HEALTH CARE QUALITY; HEALTH PROMOTION;

DIABETES MELLITUS; HEALTH PROMOTION; HUMANS; PROGRAM EVALUATION;

EID: 59449109421     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.28.1.57     Document Type: Article

References (5)

1. R.Z. Goetzel, "Do Prevention or Treatment Services Save Money? The Wrong Debate," Health Affairs 28, no. 1 (2009): 37-41;
2. and L.B. Russell, "Preventing Chronic Disease: An Important Investment, But Don't Count on Cost Savings," Health Affairs 28, no. 1 (2009): 42-45.
3. Sen. Max Baucus, "Call to Action: Health Reform 2009," 12 November 2008, http://finance.senate.gov/healthreform2009/home.html (accessed 21 November 2008).
4. W.H. Hernan et al., "Costs Associated with the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program," Diabetes Care 26, no. 1 (2003): 36-47.
5. D.M. Eddy, L. Schlessinger, and R. Kahn, "Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes," Annals of Internal Medicine 143, no. 4 (2005): 251-264.